![John P. Molloy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John P. Molloy
Direktor/Vorstandsmitglied bei
Neurochem (International) Ltd.
Profil
John P.
Molloy is currently the Director at Neurochem (International) Ltd. He previously held positions as the President & Chief Executive Officer at PARTEQ Innovations, Chairman at SPARQ Systems, Inc. (Canada), Director at BELLUS Health, Inc., Director at Performance Plants, Inc., and Director at Ontario Genomics Institute (Private Equity).
Mr. Molloy obtained an MBA from Queen's University in 1984 and an undergraduate degree from Royal Military College in 1976.
Aktive Positionen von John P. Molloy
| Unternehmen | Position | Beginn |
|---|---|---|
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing and partnering activities | Direktor/Vorstandsmitglied | 11.01.2010 |
Ehemalige bekannte Positionen von John P. Molloy
| Unternehmen | Position | Ende |
|---|---|---|
SPARQ Systems, Inc. (Canada)
 SPARQ Systems, Inc. (Canada) SemiconductorsElectronic Technology Develops and sells advanced photovoltaic microinverters for residential solar systems | Vorsitzender | - |
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute invests in companies located in Canada. The firm targets companies operating in the fields of Human health, Agriculture & Food, Bioproducts & environment. | Corporate Officer/Principal | - |
PARTEQ Innovations
 PARTEQ Innovations Investment ManagersFinance PARTEQ Innovations makes equity and debt investments to commercialize technologies developed in their life and physical sciences programs. It provides financing for early stage capital requirement with an investments range from $50,000 to $150,000. | Vorstandsvorsitzender | - |
Performance Plants, Inc.
 Performance Plants, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology solutions | Direktor/Vorstandsmitglied | - |
| BELLUS HEALTH | Direktor/Vorstandsmitglied | - |
Ausbildung von John P. Molloy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
Performance Plants, Inc.
Performance Plants, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology solutions | Commercial Services |
SPARQ Systems, Inc. (Canada)
SPARQ Systems, Inc. (Canada) SemiconductorsElectronic Technology Develops and sells advanced photovoltaic microinverters for residential solar systems | Electronic Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurochem (International) Ltd.
Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing and partnering activities | Commercial Services |
PARTEQ Innovations
PARTEQ Innovations Investment ManagersFinance PARTEQ Innovations makes equity and debt investments to commercialize technologies developed in their life and physical sciences programs. It provides financing for early stage capital requirement with an investments range from $50,000 to $150,000. | Finance |
Royal Military College
 Royal Military College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute invests in companies located in Canada. The firm targets companies operating in the fields of Human health, Agriculture & Food, Bioproducts & environment. | Finance |
